Sign in

Mohamed Elshenawy

Director at AACT
Board

About Mohamed Elshenawy

Mohamed Elshenawy is a technology executive and independent director with deep AI, robotics, and autonomous systems experience. He serves as a Class II Director of Kodiak AI, Inc., having first joined the Legacy Kodiak board in July 2025; he is 51 years old . His background includes President & CTO and Executive VP roles at Cruise, senior engineering leadership at Amazon, and currently CTO of Hims & Hers Health, Inc., a telehealth company; he holds dual B.S. degrees in Computer and Electrical Engineering (Ain Shams University) and an MBA from Texas A&M University—Commerce, with more than 10 patents in AI and robotics .

Past Roles

OrganizationRoleTenureCommittees/Impact
Cruise LLCPresident & Chief Technology OfficerNov 2023 – Apr 2025Led technology and operations in autonomous vehicles; senior leadership accountability
Cruise LLCExecutive Vice PresidentFeb 2022 – Dec 2023Executive oversight of engineering and scaling programs
Cruise LLCSVP EngineeringDec 2019 – Feb 2022Built and led engineering orgs for self-driving stack
Amazon.com, Inc.Senior engineering leadership rolesPrior to Dec 2019Cloud-scale systems and product engineering leadership (roles not specifically enumerated)
Legacy KodiakDirectorJul 2025 – Business CombinationPre-combination governance and board build-out

External Roles

OrganizationRoleTenureCommittees/Impact
Hims & Hers Health, Inc. (telehealth)Chief Technology OfficerSince May 2025Scaled digital health platforms; AI-enabled patient experience

Board Governance

  • Committee assignments:
    • Compensation Committee member; the Board has determined all committee members are non‑employee directors and meet Nasdaq independence requirements; chair is Scott Tobin .
    • Nominating & Corporate Governance Committee member; committee members meet Nasdaq independence requirements; chair is Kristin Sverchek .
  • Audit Committee: not listed as a member .
  • Independence: Affirmed via committee independence determinations under Nasdaq rules .
  • Attendance and executive sessions: Not disclosed in available filings.

Fixed Compensation

ComponentAmount/TermsPeriod
Cash fees (annual retainer, meeting, committee)None; prior to Business Combination there was no formal non‑employee director cash program; no director compensation paid for FY2024FY2024
Expense reimbursementReasonable out‑of‑pocket reimbursements for board and committee serviceOngoing

Performance Compensation

Award TypeGrant DateQuantityGrant‑Date Fair ValueVesting/Notes
Stock options (Legacy Kodiak Common Stock)2025 (initial appointment)276,414 options$1,625,314 (Elshenawy)Options granted in connection with initial board appointment in 2025; program had no cash fees pre‑combination
  • Performance metrics tied to compensation (EBITDA, TSR, ESG): Not disclosed.
  • Clawback framework: Compensation Committee oversees adoption/amendment of any clawback policy (company‑wide governance) .

Other Directorships & Interlocks

CompanyRolePotential Interlock/Conflict Note
Hims & Hers Health, Inc.CTOExternal operating role in telehealth; no related‑party transactions disclosed with Kodiak/AACT
Ares Acquisition Sponsor (AACT Sponsor) holding in KodiakN/AAACT Sponsor and affiliate investors collectively hold 15.5% of Kodiak Common Stock post‑combination, indicating sponsor influence in the combined entity’s governance ecosystem

Expertise & Qualifications

  • Technical: AI/ML, robotics, autonomous vehicles; more than 10 patents .
  • Leadership: CTO/President roles at Cruise; CTO at Hims; senior Amazon engineering leadership .
  • Education: Dual B.S. in Computer Engineering and Electrical Engineering (Ain Shams University); MBA (Texas A&M University—Commerce) .
  • Board orientation: Technology and innovation expertise explicitly cited by company as qualification for board service .

Equity Ownership

HolderShares Beneficially Owned (Common)% CommonNotes
Mohamed Elshenawy<1%Listed with less than 1% beneficial ownership; no Preferred Stock reported

Governance Assessment

  • Board effectiveness: Strong technology domain expertise; seats on Compensation and Nominating committees support oversight of pay and board composition; independence affirmed under Nasdaq for both committees .
  • Ownership alignment: Large initial option grant aligns long‑term incentives but current beneficial ownership is under 1%, limiting near‑term “skin‑in‑the‑game” signal .
  • Conflicts and interlocks: No related‑party transactions disclosed for Elshenawy; structural sponsor influence via AACT Sponsor’s stake in Kodiak warrants continued attention to independence in compensation and governance decisions .
  • Compensation structure signals: No cash fees in FY2024; emphasis on equity options for initial appointment indicates at‑risk, performance‑linked orientation, but specific performance conditions not disclosed .

RED FLAGS to monitor:

  • Limited beneficial ownership (<1%) may weaken alignment compared to larger owner‑directors .
  • Sponsor influence (15.5% stake) increases importance of robust independent committee oversight to avoid pay or nomination entrenchment .
  • Absence of disclosed performance metrics for director equity awards reduces transparency on pay‑for‑performance linkage .

Citations: